Editorials
Vol. 5 No. 1 (2026)
In this issue
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 18 March 2026
45
Views
14
Downloads
Authors
Downloads
Download data is not yet available.
Citations
1. Zanon E, Castaman G, Federici AB, et al. Bioequivalence of von Willebrand factor-containing concentrates: implications for the choice in patients with von Willebrand disease. A position paper from the Italian Association of Hemophilia Centers. Bleeding Thromb Vasc Biol 2026;5: 415. DOI: https://doi.org/10.4081/btvb.2026.415
2. Barcellona D. Cardiovascular risk in hormone replacement therapy. Bleeding Thromb Vasc Biol 2026;5:411. DOI: https://doi.org/10.4081/btvb.2026.411
3. Martini T, Valpreda A, Marchetti M, et al. Diagnostic challenges in current laboratory practice at Italian Hemophilia Centers: findings from a nationwide survey. Bleeding Thromb Vasc Biol 2026;5:431. DOI: https://doi.org/10.4081/btvb.2026.431
4. Harimadhavan M, Ram B, Karthick RG, et al. Thrombophilia work-up and clinical outcomes in Indian patients with unprovoked venous and arterial thrombosis aged 18-50 years. Bleeding Thromb Vasc Biol. 2026;5:193. DOI: https://doi.org/10.4081/btvb.2026.193
5. Lunghi B, Morfini M, Linari S, et al. Pharmacokinetics of extended half-life albumin-fused factor IX and heterogeneous F9 variants in hemophilia B: a retrospective cohort study. Bleeding Thromb Vasc Biol 2026;5:413. DOI: https://doi.org/10.4081/btvb.2026.413
6. Tripodi A. Direct oral anticoagulants: does one dose fit all? Why, when and how testing. Bleeding Thromb Vasc Biol 2026;5:418. DOI: https://doi.org/10.4081/btvb.2026.418
7. Di Castelnuovo A, Persichillo M. Cardiovascular risk profile evolution over 15 years: comparison between CV-PREVITAL Trial and Moli-sani Study participants. Bleeding Thromb Vasc Biol 2026;5:416. DOI: https://doi.org/10.4081/btvb.2026.416
8. Martini T, Gorio C, Dainese C, Santoro RC, Castaman G. Hemophilia-free mind: a call to action. Bleeding Thromb Vasc Biol 2026;5:465. DOI: https://doi.org/10.4081/btvb.2026.465
9. Candura F, Marchesini E, Forni GL, et al. Launch of a National Registry for Congenital Hematological Disorders in Palestine: the Haemo-PAL Initiative. Bleeding Thromb Vasc Biol 2026;5:417. DOI: https://doi.org/10.4081/btvb.2026.417
10. Aiello S, Benigni A, Remuzzi G. Comments on “Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy in Nigeria (PIPSICKLE): a randomised controlled trial”. Bleeding Thromb Vasc Biol 2026;5:463. DOI: https://doi.org/10.4081/btvb.2026.463
11. Bonanni A. A lifetime in biomedical research: an interview with Silvio Garattini. Bleeding Thromb Vasc Biol 2026;5:466. DOI: https://doi.org/10.4081/btvb.2026.466
How to Cite
1.
de Gaetano G, Cerletti C. In this issue. Bleeding Thromb Vasc Biol [Internet]. 2026 Mar. 18 [cited 2026 Mar. 28];5(1). Available from: https://www.btvb.org/btvb/article/view/472
Copyright (c) 2026 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Similar Articles
- Giovanni de Gaetano, Well begun is half done , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 3 (2022)
- Valerio De Stefano, Science and scientists under attack , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
- Anna Falanga, Benjamin Brenner, Alok A. Khorana, Welcome to the 12th International Conference on Thrombosis and Hemostasis Issues in Cancer! , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. s1 (2024)
- Alice Lipari, Esmeralda Capristo, Antonietta Ferretti, Erica De Candia, Anticoagulation in obese patients: challenges and strategies , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 3 (2025)
- PO16 | Antithrombotic treatment and outcomes in retinal vein occlusion: a retrospective cohort study and comparison with historical group , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO82 | Retrospective application of the TH2 score in a multicenter cohort of ITP patients: a reliable predictive tool or a score in need of refinement? , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CO01 | Statin therapy for the prevention of venous thromboembolism in cancer patients: a systematic review and meta-analysis , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO18 | Does muscle mass matter? Appendicular lean mass as a determinant of anti-XA activity in elderly patientes , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO84 | Beyond the scores: unmasking a silent pulmonary embolism in essential thrombocythemia , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CS03 | Khorana risk score and genomic profiling for prediction of venous thromboembolism in ovarian cancer , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
You may also start an advanced similarity search for this article.
